Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
Plex Research is partnering with Ginkgo Bioworks to use AI to deepen understanding of the mechanisms of action of existing ...
8h
News Medical on MSNOICR funds five innovative cancer drug discovery projectsThe Ontario Institute for Cancer Research (OICR) has announced its support for five Ontario research teams working to develop the next generation of medicines that kill tumours more effectively, cause ...
Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...
Explore more
Quantum computing systems and software company D-Wave Quantum Inc. has partnered with the pharmaceutical division of Japan ...
Americans pay a lot of money for prescription medications. In 2023, spending on prescription drugs in the United States ...
New center will use cutting-edge AI to accelerate the creation of life-saving medicines AI Small Molecule Drug Discovery ...
Leading artificial intelligence (AI) driven drug discovery and bioinformatics, Dr. Sita Sirisha Madugula is making ...
Developing new drugs to treat illnesses has typically been a slow and expensive process. However, a team of researchers at ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results